Neuropace Inc (NPCE) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.05x
Neuropace Inc (NPCE) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2026, meaning its operating cash flow of $-3.90 Million could theoretically repay 0% of its total liabilities ($85.11 Million) in one year. See Neuropace Inc (NPCE) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.05x
Operating CF / Total Liabilities
Operating Cash Flow
$-3.90 Million
USD
Total Liabilities
$85.11 Million
USD
Data as of
Jun 2026
Most recent filing
Neuropace Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Neuropace Inc across 7 annual periods. For the full cash flow conversion analysis, see NPCE cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Neuropace Inc (2019–2025)
Year-by-year debt coverage analysis for Neuropace Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.13x | $-11.01 Million | $86.53 Million | ▲ +38.6% |
| 2024 | -0.21x | $-17.95 Million | $86.63 Million | ▲ +8.5% |
| 2023 | -0.23x | $-19.70 Million | $87.00 Million | ▲ +51.3% |
| 2022 | -0.46x | $-36.87 Million | $79.33 Million | ▼ -13.6% |
| 2021 | -0.41x | $-24.58 Million | $60.06 Million | ▼ -285.9% |
| 2020 | -0.11x | $-21.61 Million | $203.78 Million | ▲ +36.3% |
| 2019 | -0.17x | $-25.03 Million | $150.44 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.